Affiliation:
1. Volgograd State Medical University
2. Volgograd Regional Clinical Hospital No. 1
3. Research Institute of Hygiene, Toxicology and Occupational Pathology
Abstract
Aim – to study the features of local production of IL-4, IL-6, IL-8, IL-10 in middle age and old age persons with chronic rhinosinusitis.
Material and methods. The study included patients aged 45 to 90 years with a confirmed diagnosis of "chronic rhinosinusitis" in the acute stage, who gave written informed consent to the study. The scope of the laboratory examination included determination of the cytokines IL-4, IL-6, IL-8, IL-10 concentration in nasal secretions by enzyme immunoassay.
Results. The maximum level of IL-4 was registered in younger persons with chronic rhinosinusitis (45–59 years old) compared with older persons. In our study, the maximum content of IL-6 occurred in a group of patients aged 75–90 years, while the cytokine level significantly exceeded IL-6 in a group of healthy age-related patients, which indicates a more pronounced inflammatory reaction in patients of the oldest group with chronic rhinosinusitis. Cytokine levels above 600 pg/ml were found mainly in patients with chronic rhinosinusitis. Patients of group 4 had high IL-10 values going beyond the range of the comparison groups.
Conclusion. The maximum level of macrophage-monocytic cytokines (IL-6 and IL-8) and anti-inflammatory IL-10 was determined in nasal lavage fluid in patients with chronic rhinosinusitis aged 75–90 years, the highest detectable values of IL-4 were characteristic of patients aged 45–59 years.
Publisher
FSBEI of Higher Education SamSMU of Ministry of Health of the Russian Federation
Reference9 articles.
1. Fokkens WJ, Lund VJ, Mullol J, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl. 2012;23:3:1-298. PMID: 22764607
2. Shamkina PA, Krivopalov AA, Ryazantsev SV, et al. Epidemiology of chronic rhinosinusitis Modern problems of science and education. 2019;3:188. (In Russ.). [Шамкина П.А., Кривопалов А.А., Рязанцев С.В., и др. Эпидемиология хронических риносинуситов. Современные проблемы науки и образования. 2019;3:188]. EDN SQILCY
3. Tataurshchikova NS. Rational pharmacotherapy of the pathologically changed immune system of nasal mucosa in patients presenting with allergic rhinitis. Bulletin of Otorhinolaryngology. 2013;78(5):93-97. (In Russ.). [Татаурщикова Н.С. Рациональная фармакотерапия патологии иммунитета слизистой оболочки носа у больных с аллергическим ринитом. Вестник оториноларингологии. 2013;78(5):93-97]. PMID: 24600715
4. Chronic rhinosinusitis: pathogenesis, diagnosis and principles of treatment: clinical recommendations. Ed. by A.S. Lopatin. M., 2014. (In Russ.). [Хронический риносинусит: патогенез, диагностика и принципы лечения: клинические рекомендации. Под ред. А.С. Лопатина. М., 2014. ISBN 978-5-98811-288-4
5. Tsybikov NN, Egorova EV, Ivanov MO, et al. Coagulating and fibrinolytic properties of nasal secretion in patients with chronic rhinosinusitis. Transbaikal Medical Bulletin. 2018;4:87-93. (In Russ.). [Цыбиков Н.Н., Егорова Е.В., Иванов М.О., и др. Коагулирующие и фибринолитические свойства назального секрета у больных хроническими риносинуситами. Забайкальский медицинский вестник. 2018;4:87-93]. https://doi.org/10.52485/19986173_2018_4_87 EDN YSTWMH